Tempus AI Inc (TEM): Next-Year EPS Estimate 113.46%
As of 2026-08-25, Tempus AI Inc (TEM) has a next-year EPS growth estimate of 113.46%. Featured in 2 EPS revision reports, most recently on 2026-08-21.
On 2026-08-14, analyst consensus for TEM's next-year EPS growth shifted from 97.35% to 113.46% — a positive change of 16.11 percentage points. The revised estimate has been sustained across 10 subsequent trading sessions. Current-year growth is projected at 65.57%.
What's Driving This
TEM’s rise is primarily underpinned by a post-earnings EPS estimate upgrade: on 2026-08-14, analysts lifted next-year EPS growth to 113.46% from 97.35%, a +16.11 pp revision. The catalyst was Q2 2026 results, with revenue up 22% to $382M. A Nature Medicine
Generated 2026-08-25 from news as of 2026-08-25
Current Snapshot
- Sector
- Healthcare
- Industry
- Health Information Services
- EPS growth next year
- 113.46%
- EPS growth this year
- 65.57%
- EPS next quarter (est)
- -$0.07
- Last price
- $68.73
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-08-25 | 113.46% | 65.57% | -$0.07 | $68.73 |
| 2026-08-24 | 113.46% | 65.57% | -$0.07 | $66.17 |
| 2026-08-23 | 113.46% | 65.57% | -$0.07 | $72.69 |
| 2026-08-21 | 113.46% | 65.57% | -$0.07 | $72.69 |
| 2026-08-20 | 113.46% | 65.57% | -$0.07 | $66.65 |
| 2026-08-19 | 113.46% | 65.57% | -$0.07 | $61.25 |
| 2026-08-18 | 113.46% | 65.57% | -$0.07 | $49.36 |
| 2026-08-17 | 113.46% | 65.57% | -$0.07 | $51.64 |
| 2026-08-16 | 113.46% | 65.57% | -$0.07 | $52.10 |
| 2026-08-14 | 113.46% | 65.57% | -$0.07 | $52.10 |
| 2026-08-13 | 97.35% | 65.57% | -$0.07 | $54.29 |
| 2026-08-12 | 97.35% | 65.57% | -$0.07 | $54.61 |
| 2026-08-11 | 97.35% | 65.57% | -$0.07 | $55.69 |
| 2026-08-10 | 97.35% | 65.57% | -$0.07 | $55.06 |
| 2026-08-09 | 97.35% | 65.57% | -$0.07 | $52.05 |
| 2026-08-07 | 97.35% | 65.57% | -$0.07 | $52.05 |
| 2026-08-06 | 97.35% | 65.57% | -$0.07 | $46.12 |
| 2026-08-05 | 97.35% | 65.57% | -$0.07 | $46.70 |
| 2026-08-04 | 97.35% | 65.57% | -$0.07 | $47.05 |
| 2026-08-03 | 95.61% | 64.82% | -$0.07 | $46.05 |
| 2026-08-02 | 86.90% | 59.87% | -$0.11 | $43.87 |
| 2026-07-31 | 76.71% | 53.58% | -$0.12 | $43.87 |
| 2026-07-30 | 87.67% | 44.55% | -$0.14 | $44.29 |
| 2026-07-29 | 87.67% | 44.55% | -$0.14 | $41.55 |
| 2026-07-28 | 87.67% | 44.55% | -$0.14 | $42.90 |
| 2026-07-27 | 87.67% | 44.55% | -$0.14 | $42.91 |
| 2026-07-26 | 87.67% | 44.55% | -$0.14 | $42.69 |
| 2026-07-24 | 87.67% | 44.55% | -$0.14 | $42.69 |
| 2026-07-23 | 87.67% | 44.55% | -$0.14 | $46.01 |
| 2026-07-22 | 87.67% | 44.55% | -$0.14 | $46.96 |
Reports Featuring TEM
Recent News
- Tempus Study Published in Nature Medicine Demonstrates Best-in-Class Performance of PRISM2 Across Diagnostic and Prognostic ApplicationsBusiness Wire
- Beyond Mega IPOs: ICR Capital President & Chairman Don Duffy, Live from NYSEIPO-Edge.com
- Beyond Mega IPOs: ICR Capital President & Chairman Don Duffy, Live from NYSEIPO-Edge.com
- Tempus AI Inc (TEM) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% to $382. ...GuruFocus.com
- Tempus AI Inc (TEM) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% to $382. ...GuruFocus.com
- Tempus: Q2 Earnings SnapshotAssociated Press
- Tempus: Q2 Earnings SnapshotAssociated Press
- Tempus Reports Second Quarter 2026 ResultsBusiness Wire
- Tempus AI Buys Personalis in $1.7 Billion Precision Oncology DealGuruFocus.com
- TEM, PSNL Stocks Are Falling Why Morgan Stanley Still Likes Tempus AIs Personalis DealStocktwits
Screen Performance
Aggregate stats across all 2014 tickers our top-EPS-revision screen has flagged over the past 146 days.
- Median return since detection
- +3.1%
- % of tickers in the green
- 56%
- Median return on winners
- +19.9%
- Large revisions captured
- 1606
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Tempus AI Inc's next-year EPS growth estimate?▾
As of 2026-08-25, Tempus AI Inc (TEM) has a next-year EPS growth estimate of 113.46%, based on analyst consensus.
When was the latest EPS estimate revision for TEM?▾
The most recent revision occurred on 2026-08-14, when analysts adjusted the next-year EPS growth estimate from 97.35% to 113.46%.
What sector and industry does Tempus AI Inc belong to?▾
Tempus AI Inc operates in the Healthcare sector, specifically the Health Information Services industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. TEM appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Tempus AI Inc (TEM) appears here because it was detected by our daily top-EPS-revision-performer screen.